Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV-positive heart transplant recipient (and cancer survivor) Miriam Nieves meets the family of the HIV-positive donor, Brittany Newton.
New study supports U.S. guidelines for determining which people with liver cancer are eligible for a transplant.
A steep rise in drug overdose deaths during the pandemic led to greater availability of donor organs.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
The CDC’s move triggered mixed feelings from the public and laid bare a split within the health care community.
Transplant recipients, people with advanced HIV and certain people with cancer or autoimmune diseases can get an additional vaccine dose.
Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.
Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Some people with blood cancers, however, may not be as well protected.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.